The Latest in Aggressive Lymphomas

CAR T in DLBCL: Liso-cel has ‘remarkable’ efficacy in cohort

June 27, 2018

Aggressive Lymphomas

DLBCL survival improved with novel antibody-drug conjugate

June 17, 2018

Aggressive Lymphomas

British good practice paper offers MCL diagnosis pearls

June 15, 2018

Aggressive Lymphomas

FDA approves pembrolizumab for relapsed/refractory PMBCL

June 14, 2018

Aggressive Lymphomas

Chemo-free regimen appears viable in previously untreated FL

June 7, 2018

Aggressive Lymphomas

Novel antibody shifts ‘eat me/don’t eat me’ balance in refractory NHL

June 6, 2018

Aggressive Lymphomas

Overcoming TP53 mutation proves difficult in MCL

June 1, 2018

Aggressive Lymphomas

Pediatric cancers are on the rise

May 17, 2018

Aggressive Lymphomas

Adding bortezomib does not improve MCL outcomes

May 16, 2018

Aggressive Lymphomas

Study: No link between non-Hodgkin lymphoma and Q fever

May 15, 2018

Aggressive Lymphomas

Novartis CAR T-cell therapy adds a lymphoma indication

May 3, 2018

Aggressive Lymphomas

Five-year survival for non-Hodgkin lymphoma tops 71%

May 2, 2018

Aggressive Lymphomas

FDA places partial hold on trials after secondary lymphoma

April 25, 2018

Aggressive Lymphomas

PDPK1 could be novel target in MCL

April 13, 2018

Aggressive Lymphomas

New genetic subtypes could facilitate precision medicine in DLBCL

April 11, 2018

Aggressive Lymphomas